At IDWeek 2018, researchers shared results of an analysis they conducted on the CORE50 study. The adverse CV outcomes in patients with HIV were examined.
Variability in metabolic parameters has been shown to have an effect on health outcomes, but whether they have an additive effect on mortality risk and cardiovascular outcomes in the general population is...
Low levels of LDL cholesterol reduce the risk of cardiovascular disease and events. However, is it safe to reduce LDL cholesterol levels that are already low? A new study investigates.
James A. Underberg, MD, outlined recent cardiovascular outcomes evidence for PCSK9 inhibitors and discussed strategies for improving access to therapy for appropriate patients.
In a recent report, the CDC sought to establish a baseline for the CVD risk factors targeted for reduction by the Million Hearts 2022 initiative during 2017–2021 and highlights recent changes over time.
...
After noting that only modest benefits have been seen in long-term CVD prevention with aspirin, researchers examined whether bodyweight leading to misdosing could explain these results.
The USPSTF has updated its 2009 recommendations on the use of nontraditional risk factors in assessment of coronary heart disease risk, focusing on 3 risk factors.
The USPSTF has updated its 2009 recommendations on the use of nontraditional risk factors in assessment of coronary heart disease risk, focusing on 3 risk factors.
Multivitamin use is widespread around the world, believed to improve health and lower cardiovascular disease risk. However, existing evidence is conflicting. A new analysis investigates.
Researchers assessed the connection, if any, between vitamin K2 deficiency and arterial stiffness in untreated adult migraineurs compared with age- and sex-matched control participants.
